Results 251 to 260 of about 54,594 (319)

Development of broadly neutralizing antibodies against Omicron variants from existing neutralizing antibodies in clinical trials. [PDF]

Virol J
Huang Y, Lin Z, Guo X, Zhang F, Wang Y, Zhang Z, Chen J, Liu L, Zhu M, Li Y, Ni M, Zhen Z, Wu Z, Ling X, Zhou S, Xi Y, Yu Y, Liang W, Zhao J, Li L, He J, Sang L.   +21 more
europepmc   +1 more source

EVOLVE platform, a trispecific T cell engager with integrated CD2 costimulation, for the treatment of solid and hematologic tumors. [PDF]

Proc Natl Acad Sci U S A
Sergeeva OA, Jin G, Sarkar M, Zeiger J, Dhindwal S, Chin SS, Abulizi A, Lai Z, Brown C, DeMaria WG, Ryan D, An X, Karp HJ, Teran E, Yuan C, Klaskin D, Reeve TA, Yu GK, Tam EM, Kaech SM, Preyer M, Matis L, Fine JS, Martomo SA, Myers JS.   +24 more
europepmc   +1 more source

Editorial for the Special Issue "Current Research on Cancer Biology and Therapeutics: Third Edition". [PDF]

Int J Mol Sci
Coveñas R.
europepmc   +1 more source

Bispecific FpFs: a versatile tool for preclinical antibody development

Matthew Collins, Nkiruka Ibeanu, Wiktoria Roksana Grabowska, Sahar Awwad, Peng T. Khaw, Steve Brocchini, Hanieh Khalili   +6 more
openalex   +2 more sources

A phase 1, first-in-human, dose escalation study of JNJ-80038114, a PSMAxCD3 bispecific antibody, in participants with metastatic castration-resistant prostate cancer. [PDF]

Cancer Chemother Pharmacol
Hudson A, Jayaram A, Garmezy B, Zorko NA, Zarrabi KK, Mathews L, Rupnow B, Li M, Ghosh D, Urtishak K, Francis P, Wang SC, Attiyeh E, de Bono J.   +13 more
europepmc   +1 more source

A novel single-vector featuring bidirectional promoters for production of bispecific antibody against rabies virus. [PDF]

BMC Biotechnol
Zhang Z, Li J, Lin G, Cao S, Wu Y.
europepmc   +1 more source

Editorial: Unveiling the next generation of cancer immunity & immunotherapy. [PDF]

Front Immunol
Sadasivam M, Muniraj N, Thangavel C.
europepmc   +1 more source

Mass Spectrometry Profiling of Therapeutic Antibodies in Multiple Myeloma: <i>m</i>/<i>z</i> Features and Concordance with Immunofixation Electrophoresis. [PDF]

Biomedicines
Pello R, Iglesias MÁ, Vidal R, Mateos R, Outón M, Agulló C, Varo N, Blanco-Sánchez A, López-Muñoz N, García Á, Miras F, Iñiguez R, Gil-Alós D, Alonso R, López EA, Martínez-López J, Cedena MT.   +16 more
europepmc   +1 more source

Linvoseltamab in multiple myeloma: a BCMA × CD3 bispecific antibody for relapsed and refractory disease. [PDF]

Ann Med Surg (Lond)
Khan G, Haider E, Imtiaz A, Ekouo J.
europepmc   +1 more source